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Background: Studies conducted in the USA have demonstrated that micronutrients such as 
folate and vitamin B12 play a significant role in modifying the natural history of high-risk human 
papillomaviruses (HR-HPVs), the causative agent for developing invasive cervical cancer (CC) 
and its precursor lesions.
Objective: The purpose of the current study was to investigate whether these micronutrients 
have similar effects on HR-HPV infections in Indian women.
Methods: The associations between serum concentrations of folate and vitamin B12 and 
HR-HPV infections were evaluated in 724 women who participated in a CC screening study 
in the southern state of Andhra Pradesh, India. Serum folate and vitamin B12 concentra-
tions were measured by using a competitive radio-binding assay. Digene hybrid capture 2 
(HC2) assay results were used to categorize women into two groups, positive or negative for 
HR-HPVs. Unconditional logistic regression models specified a binary indicator of HC2 
(positive/negative) as the dependent variable and serum folate concentrations combined with 
serum vitamin B12 concentrations as the independent predictor of primary interest. Models 
were fitted, adjusting for age, education, marital status, parity, type of fuel used for cooking 
and smoking status.
Results: Women with higher concentrations of serum folate (6 ng/mL) and vitamin B12 
(356 pg/mL) were at lower risk of being positive for HR-HPVs compared to those with serum 
folate 6 ng/mL and serum vitamin B12  356 pg/mL (odds ratio = 0.26; 95% confidence 
interval: 0.08–0.89; P = 0.03).
Conclusions: These results demonstrated that improving folate and vitamin B12 status in Indian 
women may have a beneficial impact on the prevention of CC. Micronutrient based interven-
tions for control of HR-HPV infections may represent feasible alternatives to vaccine based 
approaches to HPV disease prevention, which are currently unaffordable for use in resource 
limited areas in rural India.
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Introduction
Folate and vitamin B12 play important roles as inhibitors of human carcinogenesis 
in several organs. These micronutrients are particularly important for cancers in the 
cervix because high-risk human papillomaviruses (HR-HPVs), classified as a human 
carcinogen, play a causative role in cervical carcinogenesis. Because millions of women 
worldwide continue to be exposed to at least 13 types of known HR-HPVs (16, 18, 
31, 33, 35, 39, 45, 51, 52, 56, 58, 59 and 68), any novel and practical interventions International Journal of Women’s Health 2010:2 
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that are able to control these infections should make a 
significant contribution to prevention of CC.
Although the HPV vaccine development holds promise 
for reducing the incidence of CC, a type-specific prophylactic 
HPV vaccine (HPV 16/18) may reduce but not eliminate the 
risk of CC.1,2 Further, prophylactic HPV vaccines will not 
alter the course of existing HPV infections and no therapy 
has yet been identified to treat HPV infections. Therapeutic 
HPV vaccines have shown minimal impact on inducing 
disease regression.3 This leaves millions of women who are 
already infected with HR-HPVs with no options for receiv-
ing protection against HPV associated risk of developing 
CC other than participating in routine screening. Organized 
routine CC screening programs are largely unavailable in 
developing countries including India. In addition to these 
concerns, even considerations for use of HPV vaccine in 
developing countries include the affordability and cost-
effectiveness and the likelihood of cultural acceptability, 
political will, and public support. Therefore, nonvaccine 
approaches for control of HPV infections and ultimately 
the prevention of CC by these means are likely to be more 
practical, affordable and acceptable, especially in devel-
oping countries. Even with eventual availability, because 
of the higher cost, it is important to find adjuncts that are 
able to maximize the cost-effectiveness of HPV vaccines. 
Micronutrients such as folate and vitamin B12 are likely to 
be efficient as adjuncts as they have a positive influence on 
immune response in humans.4–7
Our recent studies conducted at the University of Alabama 
at Birmingham (UAB) in the USA have demonstrated that 
higher circulating concentrations of folate (a B vitamin natu-
rally present in fruits and vegetables as folate and in fortified 
foods as folic acid) are associated with a lower likelihood 
of becoming HR-HPV positive and of having a persistent 
HR-HPV infection, and when infected, a greater likelihood 
of clearing HR-HPV .8 Recent studies have reported similar 
findings.9 Our studies have also demonstrated that women 
with lower folate status and positive for any of the 13 types 
of HR-HPV were twice more likely to have higher grades of 
cervical intraepithelial neoplasia (CIN 2+) which are precur-
sor lesions for CC. More importantly, we also demonstrated 
that women with lower folate and positive for HPV-16 were 
9× more likely to have CIN 2+, strongly suggesting a specific 
effect of folate on HPV 16,10 the most commonly found and 
most carcinogenic type of HPV . Findings from our recent 
studies also demonstrate that in populations exposed to 
higher folate as a result of population-wide folic acid forti-
fication programs, women with sufficient vitamin B12 status 
benefit most from higher folate status compared to women 
with lower/insufficient circulating concentrations of both 
micronutrients.11 These associations held after controlling 
for other micronutrients and other known risk factors for CC 
strongly suggesting a positive role for folate and vitamin B12 
in early cervical carcinogenesis.
These micronutrients are likely to be more important 
in countries such as India where deficiencies of these 
micronutrients are more frequent than in developed coun-
tries. The purpose of the current study was to investigate 
whether there are associations between folate and vitamin 
B12 and the likelihood of being positive for HR-HPVs in 
Indian women.
Material and methods
study population
The current study was conducted on the first 724 women 
enrolled in the Community Access to Cervical Health 
(CATCH) study, in a population-based sample of women 
living in the southern state of Andhra Pradesh, India, which 
was designed to compare three methods of CC screening.12 
The study was approved by the SHARE Research/Mediciti 
Institute of Medical Sciences and Johns Hopkins Bloomberg 
School of Public Health.
Methods
A questionnaire was administered to gather information 
regarding age, education, marital status, parity, type of fuel 
used for cooking (gas or firewood, thought to be not only an 
indicator for socioeconomic status, but also a known risk 
factor for CC13) and exposure to tobacco smoke (by smoking 
or by exposure to second-hand smoke, but largely due to 
second-hand exposure). The questionnaire was administered 
after consent and before the pelvic exam was performed 
(ie, prior to knowing HPV status). Blood samples were 
collected from women between 10 am and 2 pm and we did 
not gather information on fasting/nonfasting status. Samples 
were clotted at room temperature, centrifuged and aliquotted 
for -80 °C storage within 8 hours. Serum folate and vitamin 
B12 concentrations were measured by using a competitive 
radio-binding assay (SimulTRAC-SNB; MP Biomedicals, 
Orangeburg, NY). Cervical samples were collected using 
the Digene cervical brush sampler and placed in standard 
transport medium (STM) which was stored at -20 °C until 
tested. Digene Hybrid Capture 2 (HC2) assay (Qiagen Inc. 
Valencia, CA) detects 13 HR-HPV infections (HPV16, 
18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, and 68) and 
was performed according the manufacturer’s instructions. International Journal of Women’s Health 2010:2 
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Women were considered positive for HR-HPV if the relative 
light unit/cutoff (RLU/CO) was 1.0.
Statistical analysis
Serum folate and vitamin B12 concentrations of the 
study population were analyzed using standard cutoff 
points: folate,  3 ng/mL as deficient and 3 ng/mL as 
sufficient, and vitamin B12, 203.3 pg/mL as deficient 
and 203.3 pg/mL as sufficient. Descriptive statistics were 
used to characterize the 79 women who tested positive 
for HR-HPVs and 645 women who tested negative for 
HR-HPVs. The Pearson chi-square statistic was used 
to assess differences between observed and expected 
frequencies. Proportions were compared using a two-sided 
chi-square test.
Unconditional logistic regression models specified 
a binary indicator of HC2, positive or negative as the 
dependent variable. Serum concentrations of folate and 
vitamin B12 were examined as potential independent risk 
factors, adjusting for age (in increments of 5 years from 
25 years to greater than 60 years), education (1st–9th 
standard or greater [9+] vs none), marital status (married 
vs divorced/separated/widowed), parity (3, 1–2 or 0 live 
births), type of fuel used for cooking (firewood vs gas) and 
exposure to tobacco smoke (yes vs no). In a variation of the 
model described above, we specified combined categories 
of serum folate and vitamin B12 as independent predictors 
of primary interest. Study population-based cutoff points 
(comparing the highest tertile to the remaining lower 
2 tertiles) for folate and vitamin B12 were 6 ng/mL and 
356 pg/mL, respectively. Individual effects of folate and 
vitamin B12 on the likelihood of being HR-HPV-positive 
was tested against these cutoff points in the regression 
models. We then categorized the women into four catego-
ries to examine the joint effects of folate and B12: higher 
folate (6 ng/mL) and higher vitamin B12 (356 pg/mL) 
(n = 88), lower folate (6 ng/mL) and higher vitamin B12 
(356 pg/mL) (n = 154), higher folate (6 ng/mL) and 
lower vitamin B12 (356 pg/mL) (n = 155), and lower 
folate (6 ng/mL) and lower vitamin B12 (356 pg/mL) 
(n = 327). The referent group was women who had low 
concentrations of both micronutrients. We evaluated the 
strength of each association by estimating the odds ratio 
(OR) and its 95% confidence interval (CI), and its statis-
tical significance using Wald’s chi-square statistic of the 
null hypothesis that the OR = 1. All statistical analyses 
were conducted using SAS® Version 9.1.3 (SAS Institute, 
Cary, NC).
Results
Compared to standard cutoff points, vitamin B12 deficiency 
was more common than folate deficiency in this population 
of women, according to established cutoff points for the 
normal ranges of these micronutrients. We also observed 
that almost half the population (47%) was sufficient in 
both micronutrients. However, 42% were deficient for 
one of the micronutrients and 11% were deficient in both 
micronutrients.
The prevalence of HR-HPV by demographic and life-
style factors and serum concentrations of folate and vitamin 
B12 is shown in Table 1. Women above the age of 45 years 
had a higher prevalence of HR-HPV compared to women 
of child bearing age (25–44 years) but it was statistically 
non-significant (P = 0.08). Prevalence of HR-HPV was 
Table 1 Prevalence of HR-HPV by demographic/lifestyle factors 
and serum concentrations of folate and vitamin B12
Details Number % P–
HPV+ Total HPV+ value
Age at enrollment (years)
25–44 59 593 9.9 0.08
45+ 20 131 15.3
Education
none 58 474 12.2 0.12
1st–9th standard or greater (9+) 21 250 8.4
Marital status
Married 69 646 10.7 0.57
Divorced/separated/widowed 10 78 12.8
Parity
0 live birth 3 37 8.1 0.58
1–2 live births 28 285 9.8
3 live births 48 402 11.9
Cooking fuel
Firewood 38 358 10.6 0.80
gas 41 366 11.2
Exposure to tobacco smoke
Yes 48 356 13.5 0.03
no 31 368 8.4
Micronutrient concentrations by cut point  
serum folate (ng/mL)
6 22 243 9.1 0.25
6 57 481 11.9
Serum vitamin B12 (pg/mL)
356 24 242 9.9 0.54
356 55 482 11.4
Abbreviations: HR-HPVs, high-risk human papillomaviruses.International Journal of Women’s Health 2010:2 10
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more common among women who were exposed to smoke 
(from tobacco use or second-hand smoke) compared to 
women who were not exposed (P = 0.03). Prevalence of 
HPV did not significantly differ by the categories of other 
variables including serum concentrations of folate and 
vitamin B12.
When the association between the two micronutri-
ents and likelihood of being positive for HR-HPV was 
tested individually, we observed that only the highest tertile 
values for folate (6 ng/mL) and vitamin B12 (356 pg/mL) 
showed a lower risk of being positive for HR-HPVs 
(20% reduced risk for both micronutrients and statistically 
nonsignificant). Therefore, in the logistic regression models 
the combined effects of serum folate and vitamin B12 were 
tested with these two combinations against the reference 
category of folate 6 ng/mL and vitamin B12  356 pg/mL 
(Table 2). Results demonstrated that women with higher 
concentrations of serum folate (6 ng/mL) and vitamin 
B12 (356 pg/mL) were at lower risk of being positive 
for HR-HPVs compared to those women with serum 
folate 6 ng/mL and vitamin B12  356 pg/mL (OR = 0.26, 
95% CI 0.08–0.89, P = 0.03). Our results also suggested that 
higher concentrations of folate or vitamin B12 in isolation 
do not appear to reduce the likelihood of being infected 
with HR-HPVs. In addition, we also observed that exposure 
to tobacco smoke was associated with higher risk of being 
positive for HR-HPVs.
Discussion
To our knowledge, our study is the first large scale 
community-based study to determine folate and B12 
concentrations among Indian women in relation to risk 
of HR-HPV infections. We observed that vitamin B12 
deficiency is much more common than folate deficiency in 
this study population. These results, however, are in con-
cordance with the findings from small studies in selected 
or hospital-based Indian populations. In a study conducted 
in Pune, nearly 50% of the population had vitamin B12 
deficiency while only 5% of the population had folate 
deficiency.14 Similarly, another small study observed that 
46% of women had deficient circulating concentrations 
of vitamin B12 while only 12% of women had deficient 
concentrations of folate.15
This study suggested that having higher intakes of 
both micronutrients are required to receive maximum 
protection against infections with HR-HPVs. Biological 
mechanisms by which folate and vitamin B12 could 
modify the risk of being infected with HR-HPVs are highly 
plausible. Reduced immunocompetence associated with 
deficiencies of folate and vitamin B124,5,16 could increase 
the risk of infection and persistence with multiple types 
or higher viral loads of HR-HPVs. Vitamin B12 is an 
important micronutrient in the folate metabolic pathway 
which provides nucleic acids for DNA synthesis. Above 
average intakes of folate and vitamin B12 are shown to be 
associated with reduced genome damage rate as measured 
by using the micronucleus assay.17 Reduced DNA damage 
associated with higher folate and vitamin B12 status is 
likely to reduce the integration of HPV into the human 
genome and allow HPVs to stay as episomal. A common 
chromosomal fragile site that is sensitive to folate defi-
ciency has been shown to coincide with a site of HPV-16 
integration in the tissues of primary cervical carcinomas18 
and three of the four sites at which HPV-18 integrates its 
DNA into the host,19 suggesting a plausible mechanism 
through which suboptimal folate levels could increase 
the likelihood of integration with these HPV genotypes.20 
Therefore, control of HR-HPV infections by improvements 
Table 2 Relationship of serum folate and serum vitamin B12 
interaction and other factors with HR-HPV infections
Risk factors OR (5% CI) P-value
Age at enrollment (increments  
of 5 years from 24–60)
1.02 (0.89–1.18) 0.75
Education
none 1.00 (reference) 0.30
1st–9th standard or greater (9+) 0.72 (0.38–1.34)
Marital status
Divorced/separated/widowed 1.00 (reference) 0.66
Married 0.84 (0.38–1.84)
Parity (3, 1–2 , 0 live births) 1.09 (0.70–1.71) 0.70
Cooking fuel
gas 1.00 (reference) 0.46
Firewood 0.82 (0.48–1.39)
Smoking exposure
no 1.00 (reference) 0.05
Yes 1.70 (1.01–2.85)
Folate and vitamin B12 combinations
Folate  6 ng/mL,  
vitamin B12  356 pg/mL (n = 327)
1.00 (reference)
Folate  6 ng/mL,  
vitamin B12  356 pg/mL (n = 88)
0.26 (0.08–0.89) 0.03
Folate  6 ng/mL,  
vitamin B12  356 pg/mL (n = 154)
1.22 (0.67–2.22) 0.53
Folate  6 ng/mL,  
vitamin B12  356 pg/mL (n = 155)
1.15 (0.63–2.10) 0.64
Abbreviations: HR-HPVs, high-risk human papillomaviruses; OR, odds ratio; 
CI, confidence interval.International Journal of Women’s Health 2010:2 11
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in folate and vitamin B12 status is likely to be an important 
nonvaccine-based approach for preventing HR-HPV 
associated risk of developing CC.
However, implementation of supplementation programs 
with folate and vitamin B12 for control of HPV infections 
in Indian women based on our results may be premature 
for the following reasons. This study was not designed to 
measure other important cancer protective micronutrients 
such as antioxidants (eg, vitamins C, A, E, carotenes) and 
this could be a limitation of the study. Even though these 
other micronutrients were not shown to play an important 
role for HPV natural history in our US study populations, 
they may play important roles in Indian women where 
the intake of these micronutrients could be lower than 
in US. In fact, the report of National Nutrition Monitor-
ing Bureau, India. (technical report 21:2002) “Diet and 
Nutritional Status of Rural Population”, revealed that the 
median and mean intakes of all micronutrients were well 
below the RDA for Indians. Oxidative stress induced by 
deficiencies in antioxidant micronutrients is likely to 
perturb the normal redox balance and transform the HPV-
infected cells toward a carcinogenic process in the cervix.21 
Our study has also limited information on some important 
risk factors for CC such as lifetime number of sexual 
partners, use of oral contraceptives or vitamin supple-
ments. Additionally because of the cross sectional nature 
of our data, the role of micronutrients on HPV acquisition 
vs persistence (or both) could not be determined. There-
fore future studies that are carefully designed to address 
these limitations are needed to confirm that folate and 
vitamin B12 have independent or combined effects on 
controlling HPV infections in these women.
In summary, we demonstrated that Indian women with 
higher concentrations of both folate and vitamin B12 are 
74% less likely to test positive for HR-HPVs. Compre-
hensive studies conducted in the US demonstrated that 
women with higher folate and sufficient vitamin B12 were 
70% less likely to be diagnosed with HR-HPV associated 
higher grades of CIN 2+, which are precursor lesions for 
the development of invasive CC.5 If similar results can be 
demonstrated for Indian women, supplementation with 
folate and vitamin B12 could be a viable nonvaccine 
approach for prevention of CC in India.
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